Skip to main content
. 2016 Feb 10;6:1–8. doi: 10.1016/j.bbrep.2016.02.006

Table 1.

BCL6 and RUVBL1 staining in lymphomas.

Tumor Lymphoma type/stage RUVBL1% staining/average intensity BCL6% staining/average intensity % staining×average intensity
RUVBL1 BCL6
T cell Localized (stage 1)
1 Anaplastic large cell 80/3+ 50/2+ 240 100
2 Anaplastic large cell 85/3+ 50/2+ 255 100


 

Advanced (stages 3 and 4) 

 

 

 


3 Anaplastic large cell 80/2+ 0 160 0
4 Peripheral 80/2+ 0 160 0
5 Large cell (immunoblastic), peripheral 85/3+ 10/2.5+ 255 25
6 Large cell 80/2+ 25/2+ 160 50
7 Delta/gamma peripheral 90/3+ 25/2+ 270 50
8 Peripheral 67/3+ 30/2+ 201 60
9 Anaplastic large cell 90/3+ 40/2+ 270 80
Avr 219 51.67
B cell Localized (stage 1)
10 High grade, EBV-related 70/2+/mostly big cells 40/1.5+/mostly small cells 140 60
11 DLBL, follicular origin 50/2+ 50/1.5+ 100 75
12 Large cell, follicular origin 85/2.5+ 50/3+ 212.5 150
13 DLBL 60/2+ 70/2+ 120 140
14 DLBL, follicular center type 80/1.5+ 80/3+ 120 240
15 DLBL, non-germinal center-like 90/3+ 85/2.5+ 270 212.5


 

Advanced (stages 3 and 4) 

 

 

 


16 Mantle cell 95/3+ 5/2.5+ 285 12.5
17 DLBL 70/1.5+ 25/1.5+ 105 37.5
18 Large cell, follicular origin 60/2.5+ 25/2.5+ 150 62.5
19 DLBL, CD5+ 80/2.5+ 40/2+ 200 80
20 DLBL with anaplastic features 70/3+ 50/2+ 210 100
21 Large cell, activated B cell type 90/3+ 50/2.5+ 270 125
22 DLBL, germinal center-like 90/3+ 60/2.5+ 270 150
Avr 188.65 111.15

DLBL: Diffuse large B cell lymphoma; EBV: Epstein-Barr Virus.